Project Grant R03DK147721
- Federal Project Grant Award Summary The University of Chicago received a $6.51 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the role of macrophages in weight loss-induced metabolic health and adipose tissue inflammation resolution. Awarded on September 20, 2025, with a completion date of September 19, 2029, this research project...
- Federal Project Grant Award Summary The University of Chicago received a $770,995 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 2, 2026, with completion scheduled for November 30, 2029. The research project, titled "Intestinal Epithelial Heat Shock Protein 25/27 Integrates Host Immune and Microbial Drivers Required for...
- Federal Project Grant Award Summary The University of Chicago received a $151,040 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective December 11, 2025, with completion scheduled for November 30, 2028. The award funds fundamental biomedical research investigating how epithelial cell collectives sense and respond to directional cues during...
- Federal Grant Award Summary The University of Chicago received a Project Grant award of $147,486 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period of September 30, 2025, through September 29, 2028. The grant funds basic biomedical research investigating the regulation of exocrine pancreatic innate immunity through microbially induced Interleukin-22...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Chicago a $172,904 Project Grant (K23 career development award) effective April 1, 2026, through March 31, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports the development and validation of clinically actionable decision-support tools to individualize glucagon-like peptide-1 receptor agonist...
- Federal Grant Award Summary The University of Illinois received a $786,728 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded June 1, 2026, with completion targeted for April 30, 2031. This research project investigates the role of gut microbiota-derived 3-phenylpropionic acid (3-PPA) as a metabolic regulator of beige adipogenesis and energy...
- Federal Project Grant Award Summary Rockefeller University received a $1.55 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on September 5, 2025, with a completion date of June 30, 2030. This award funds basic biomedical research investigating the mechanisms of transcriptional control of adipocyte (fat cell) formation and function through...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $709,931 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 15, 2025, with a completion date of June 30, 2030. This award supports investigator-initiated basic biomedical research investigating neutrophil regulation of brown adipose tissue (BAT) homeostasis and its implications...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $167,363 to the University of California, Los Angeles (UCLA) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective March 1, 2026, with a completion date of February 28, 2031. The research focuses on elucidating novel central nervous system (CNS) mechanisms underlying obesity and metabolic dysfunction,...
- Federal Project Grant Award Summary The University of Washington received a $888,773 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, with completion targeted for January 31, 2031. The award supports investigator-initiated biomedical research designed to elucidate mechanisms underlying obesity pathogenesis, specifically examining...
The University of Chicago received a $123,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for research conducted from June 16, 2026, through May 31, 2028. The award funds a research project titled "Characterizing Adipocyte Heterogeneity in Response to Metabolic Stress," which aims to advance understanding of how adipose tissue contributes to metabolic disease, particularly insulin resistance and type 2 diabetes (T2D). The research deliverables include comprehensive characterization of white adipocyte subpopulations and their responses to metabolic stress conditions through an integrated approach combining bench experimentation and computational analysis. Specifically, the project will employ single-nucleus RNA sequencing and cellular models to examine how diverse stimuli—including high-fat diet and cold exposure—influence adipocyte development and specification across individuals with varying clinical characteristics. The research will generate data on intra-individual variation in adipocyte response to stimuli and establish relationships between adipocyte state and metabolic disease development, ultimately informing potential therapeutic targeting strategies for adipocyte subpopulations. Research activities are performed at the University of Chicago's Chicago, Illinois location.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $123.0k | 6/18/26 |